About Core Biogenesis
Core Biogenesis is a company based in Paris (France) founded in 2020 by Chouaib Meziadi, Maurice Moloney, and Alexandre Reeber. Core Biogenesis has raised $14.12 million across 3 funding rounds from investors including Plug and Play Tech Center, XAnge and Blue Horizon. Core Biogenesis offers products and services including Recombinant Protein Platform and Peptide Targeting Technology. Core Biogenesis operates in a competitive market with competitors including Qkine, Future Fields, KAICO, AntiCancer and Protera, among others.
- Headquarter Paris, France
- Founders Chouaib Meziadi, Maurice Moloney, Alexandre Reeber
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Core Biogenesis
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.12 M (USD)
in 3 rounds
-
Latest Funding Round
$10.97 M (USD), Series A
Mar 29, 2022
-
Investors
Plug and Play Tech Center
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Core Biogenesis
Core Biogenesis offers a comprehensive portfolio of products and services, including Recombinant Protein Platform and Peptide Targeting Technology.
Platform for producing high-value proteins using plant biofactories
Technology that targets peptides to plant oleosomes for skincare applications
People of Core Biogenesis
Unlock access to complete
Funding Insights of Core Biogenesis
Core Biogenesis has successfully raised a total of $14.12M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10.97 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Core Biogenesis
Core Biogenesis has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Plug and Play Tech Center, XAnge and Blue Horizon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on tech companies
|
Locked | Locked | Locked | |
|
Sustainable food sector ventures are invested in by Blue Horizon.
|
Locked | Locked | Locked | |
|
Provider of a program turning individuals into funded technology company founders
|
Locked | Locked | Locked |
Investor details for Core Biogenesis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Core Biogenesis
Investment portfolio details for Core Biogenesis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Core Biogenesis
Detailed financials for Core Biogenesis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Core Biogenesis Comparisons
Peer comparison for Core Biogenesis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Core Biogenesis
Core Biogenesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qkine, Future Fields, KAICO, AntiCancer and Protera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal-free growth factors are developed for life science applications.
|
|
| Locked | Locked | Locked |
Serum-free bioactive growth factors and recombinant proteins are biomanufactured.
|
|
| Locked | Locked | Locked |
Manufacturer of portfolio of proteins and other biological cytokines and enzymes
|
|
| Locked | Locked | Locked |
Reagents and models for cancer research are developed and supplied.
|
|
| Locked | Locked | Locked |
Protein-based enzyme technologies are developed using deep learning algorithms.
|
Detailed competitors of Core Biogenesis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Core Biogenesis
Complete news archive for Core Biogenesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Core Biogenesis
Core Biogenesis was founded in 2020.
Core Biogenesis is headquartered in Paris, France.
Alexandre Reeber is the current CEO of Core Biogenesis. They have also founded this company.
Core Biogenesis is a funded company, having raised a total of $14.12M across 3 funding rounds to date.
Core Biogenesis was founded in 2020 in Paris, France, within the biotechnology sector. A UBaaS platform is utilized to enable scalable bioproduction of recombinant proteins, with plants employed as biofactories for high-value bioproducts. Human growth factors are included among the outputs. Operations focus on accelerating mass production through this service model, supporting advancements in biomanufacturing.
Core Biogenesis's top competitors include Future Fields, Qkine and Algenex.
Core Biogenesis offers Recombinant Protein Platform and Peptide Targeting Technology.
Core Biogenesis has 6 investors. Key investors include Plug and Play Tech Center, XAnge, Blue Horizon, Entrepreneur First, and Thia Ventures.